Sign in
4

Changes in Ownership

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000103

Options or other derivatives

  • Director acquired 5,780 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kogan Elona Director 2025-05-16 Grant or award · Stock Option (right to buy) +5,780 5,780 D
Loading xslF345X05/primary_doc.xml…